Evaluation of optimal blood culture incubation time to maximize clinically relevant results from a contemporary blood culture instrument and media system by Ransom, Eric M et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2-18-2021 
Evaluation of optimal blood culture incubation time to maximize 
clinically relevant results from a contemporary blood culture 
instrument and media system 
Eric M Ransom 
Zahra Alipour 
Meghan A Wallace 
Carey-Ann D. Burnham 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Evaluation of Optimal Blood Culture Incubation Time To
Maximize Clinically Relevant Results from a Contemporary
Blood Culture Instrument and Media System
Eric M. Ransom,a Zahra Alipour,a Meghan A. Wallace,a Carey-Ann D. Burnhama,b,c,d
aDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
bDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA
cDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA
dDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA
ABSTRACT Timely diagnosis of microorganisms in blood cultures is necessary to
optimize therapy. Although blood culture media and systems have evolved for deca-
des, the standard interval for incubation prior to being discarded as negative has
remained 5 days. Here, we evaluated the optimal incubation time for the BacT/Alert
Virtuo blood culture detection system (bioMérieux) using FA Plus (aerobic) and FN
Plus (anaerobic) resin culture bottles in routine clinical use. Following institutional
review board (IRB) approval, a retrospective review evaluated the outcomes of 158,710
bottles collected between November 2018 and October 2019. The number of positive
blood bottles was 13,592 (8.6%); 99% of positive aerobic and anaerobic bottles
flagged positive by 91.5 and 108 h, respectively. The mean (median) times to positivity
were 18.4 h (15.6 h) for Staphylococcus aureus, 12.3 h (9.5 h) for Escherichia coli, 22.2 h
(15.9 h) for Pseudomonas aeruginosa, and 48.9 h (42.9 h) for Candida spp. Only 175
bottles (0.1% of all bottles) flagged positive after 4 days of incubation; 89 (51%) of
these bottles grew Cutibacterium (Propionibacterium) species. Chart review of blood
cultures positive after 4 days (96 h) rarely had a clinical impact and sometimes had a
negative impact on patient care. Finally, a seeded study of the HACEK group (i.e.,
Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, and Kingella), historically asso-
ciated with delayed blood culture positivity, demonstrated no benefit to extended
incubation beyond 4 days. Collectively, these findings demonstrated that a 4-day incu-
bation time was sufficient for the Virtuo system and media. Implementation of the 4-
day incubation time could enhance clinically relevant results by reducing recovery of
contaminants and finalizing blood cultures 1 day earlier.
KEYWORDS blood culture, Virtuo, time to positivity, BacT/Alert, FA Plus, FN Plus,
Staphylococcus aureus, growth rate, Cutibacterium, Escherichia coli, Pseudomonas
aeruginosa
Continuously monitored blood culture systems are used in clinical microbiology lab-oratories to test for life-threatening conditions like bacteremia, fungemia, and en-
docarditis. Historically, blood culture bottles were incubated on these systems for up
to 7 days before being discarded and reported as “no growth.” Today, a 5-day mini-
mum incubation is recommended for most commercial systems; however, there have
been reports suggesting a 5-day incubation may not be necessary for modern blood
culture systems (1–4). Optimization of the blood culture incubation period can support
clinical care, with the goal of incubating long enough to recover clinically significant
microorganisms while also minimizing the recovery of contaminants. The latter is im-
portant to minimize unnecessary antimicrobial therapy and can reduce waste in the
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clinical laboratory. In addition, a more rapid determination of a blood culture as nega-
tive has the potential to expedite patient discharges and more quickly deescalate
broad-spectrum antibiotic usage to improve antimicrobial stewardship.
Our institution implemented the BacT/Alert Virtuo (Virtuo) blood culture detection
system with FA Plus (aerobic) and FN Plus (anaerobic) resin culture bottles (bioMérieux) in
mid-2018. This system has been shown to have a faster time to positivity compared to
other systems using seeded cultures (5–7) and paired clinical cultures (8–10). These find-
ings, along with anecdotal observations from the laboratory noting mostly growth of clini-
cally insignificant microbes after 4 days of incubation, prompted a review of blood cultures
from the Virtuo system. The goal of this work was to reassess optimal incubation time and
microorganism recovery using a 1-year, retrospective analysis of Virtuo time-to-positivity
data combined with medical chart review to determine clinical utility of a 5-day incu-
bation. In addition, because they were encountered infrequently in the clinical
specimens, a seeded study was included to evaluate HACEK microorganisms
(Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, and Kingella).
MATERIALS ANDMETHODS
Clinical setting. The central microbiology laboratory at the Barnes-Jewish Institute of Health in St.
Louis, MO, serves Barnes-Jewish Hospital (a 1,250-bed tertiary care academic medical center) as well as a
stand-alone academic children’s hospital and three community hospitals in the St. Louis metropolitan
area.
Culture and identification. Following approval from the Washington University in St. Louis Human
Research Protection Office, all 158,710 blood culture bottles from November 2018 to October 2019 sub-
mitted to the laboratory were evaluated in the present study. The laboratory’s standard procedures rec-
ommend collecting blood cultures as a set consisting of two bottles: FA Plus (aerobic) and FN Plus (an-
aerobic) resin culture bottles. For adults, the recommended collection volume is 10ml per bottle (i.e.,
20ml per set), and for children, approximately 1 ml of blood per year of patient age. No bottles were
rejected by the laboratory or excluded from analyses based on blood volumes below the recommended
volume. Bottles were continuously monitored until positive for up to 5 days at 37°C on the BacT/Alert
Virtuo detection system (bioMérieux). While an extended incubation was available by physician request,
there were no requests during the time frame of this study. The Virtuo system screens bottles almost
continuously during the first 74.4 h of incubation then every 144 min thereafter. Positive bottles under-
went Gram staining and were processed according to laboratory standard operating procedures. If no
organisms were seen by Gram stain, acridine orange staining was performed and the bottles were sub-
cultured to solid medium.
All positive bottles were subcultured to agar media: sheep’s blood agar, chocolate agar,
MacConkey’s agar, or colistin-nalidixic acid agar if Gram stain reveals mixed microbes, including Gram-
positive organisms; Campylobacter selective agar if Gram stain reveals curved Gram-negative bacilli;
CandiSelect and Sabouraud dextrose agar if Gram stain reveals fungal elements or yeast; 7H11 agar if
Gram stain reveals mycobacterium-like structures; and/or Brucella blood agar if an anaerobic bottle is
flagged positive or if Gram stain is suggestive of anaerobic growth. Routine agars were incubated and
imaged on the Kiestra Total Lab Automation system (Becton, Dickinson Microbiology Systems) (11).
Anaerobic plates were incubated offline in conventional anaerobic chambers (either an Anaerobe Systems
580 or miniMACS anaerobic workstation). Microbial identification was routinely performed by matrix-
assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) with a Bruker
BioTyper (Bruker, Billerica, MA).
Data compilation. A retrospective review evaluated the outcomes of 158,710 blood culture bottles,
and, if positive, the microbial species/grouping. Bottles inoculated with non-blood specimens (e.g., pleu-
ral fluid) were excluded from analyses. Linking the recovered species to time to positivity required the
merging of two large data sets. First, all time-to-positivity data were pulled from the Virtuo system’s
MYLA middleware system using the culture accession number. Next, the reported species was pulled
from the blood culture report logs using the Cerner Millennium laboratory information system. Using
the accession number, cultures with a single positive bottle (with any number of reported species) or a
single reported species (with any number of positive bottles) were linked. For cultures with multiple bot-
tles with multiple species, these cultures required manual laboratory information system review to
determine which species were recovered from which bottles.
Medical chart review. A medical chart review in EPIC (Madison, WI) was performed on patients with
a bottle time to positivity of greater than 4 days (96 h) of incubation. Patients’ electronic health records
were reviewed for clinical actions prior to and after reporting of the blood culture. This included admis-
sion status, antimicrobial treatments, comorbidities, diagnoses, deceased status, and any mention of the
culture in the medical chart, especially from infectious disease physicians. Examples of “No Impact”
included (i) bottles with no microorganisms observed/recovered on a subculture, (ii) bottles that flagged
positive after patient expired, (iii) bottles from cultures in a two-bottle set and where the companion
bottle had a time to positivity of less than 4 days and reported the same microbe, (iv) bottles that were
specifically called out in medical record as a “contaminant” by the physician, and (v) bottles that were
from patients lost to follow-up.
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Seeded study (HACEK). Clinical isolates of HACEK microorganism recovered from frozen storage
were first subcultured, and species were confirmed by MALDI-TOF MS. The species were Aggregatibacter
aphrophilus, Cardiobacterium hominis, Eikenella corrodens, and Kingella denitrificans, identified using
MALDI-TOF MS. For the seeded study, Escherichia coli strain ATCC 25922 was included as a positive con-
trol. After subculture, a few well-isolated colonies were used to make a 1.0 McFarland standard
(;3.0 108 CFU/ml). Subsequent dilutions were used to achieve a target inoculum of 30 CFU in 5 ml of
human blood (packed red blood cell remnant units provided courtesy of the Barnes-Jewish Hospital
transfusion service). This final concentration (;6 CFU/ml) was determined by companion colony counts.
If input colony counts were ,10 or .80 CFU total on the agar plates using 0.1ml of the prior ;3 102-
CFU/ml dilution, data were excluded from analysis and retested. A saline-only inoculum was used as a
negative control. Aerobic and anaerobic bottles were inoculated in triplicate using standard practices
and incubated on the Virtuo system per routine procedures for 5 days.
RESULTS
Cohort summary. A total of 158,710 blood culture bottles were tested at the
Barnes-Jewish Hospital microbiology laboratory between November 2018 and October
2019. Of these bottles, 13,592 (8.6%) flagged positive by the 5-day incubation cutoff
(Fig. 1). The breakdowns of bottles from adults and children were 12,769 and 823,
respectively.
Time to positivity. The times for 50% and 90% of bottles to signal positive were
16.5 and 38.5 h, respectively (Table 1). The mean time to positivity was 21.1 h. After 24
h of incubation, 10,431 bottles, or 76.74%, flagged positive. An additional 2,286 bottles
flagged positive between 24 and 48 h, increasing the positivity rate to 93.56%. By the
end of 4 days, 98.71% of bottles flagged positive—all but 175 bottles. Similar trends
were observed from children (defined as #18 years of age [Fig. 2]). For the cultures col-
lected from children, 630 bottles, or 76.55%, flagged positive after 24 h of incubation;
by the end of 4 days, 99.39% flagged positive—all but five bottles.
Time to positivity under aerobic and anaerobic growth conditions. To compare
differences between aerobic and anaerobic growth conditions, the aforementioned
data were parsed into aerobic (FA) and anaerobic (FN) bottle types. For aerobic bottles,
the times until 50% and 90% of the bottles signaled positive were 15.5 and 36.5 h,
respectively (Table 1). The mean time to positivity was 20.0 h. After 24 h of incubation,
5,565 bottles, or 80.19%, flagged positive (Fig. 3, top panel). An additional 957 bottles
flagged positive between 24 and 48 h, increasing the positivity rate to 93.98%. By the
end of 4 days, 99.27% of bottles flagged positive—all but 51 bottles.
For anaerobic bottles, a broader distribution was observed spanning the first 30 h.
The times to reach 50% and 90% positivity were 17.5 and 39.5 h, respectively (Table 1).
The mean time to flag positive was 22.3 h. After 24 h of incubation, 4,866 bottles, or
FIG 1 Time to positivity for all positive blood culture bottles. Positive bottles (n=13,592) were
plotted in 30-min intervals. Of note, the BacT/Alert Virtuo system screens for positivity continuously
for the first 74.4 h and every 144 min thereafter, resulting in greater column interspersion at later
time points. After 4 days of incubation, 98.71% of all bottles flagged positive.
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73.15%, flagged positive (Fig. 3, bottom panel). An additional 1,329 bottles flagged
positive between 24 and 48 h, increasing the total positivity rate to 93.13%. By the end
of 4 days, 98.14% of bottles flagged positive—all but 124 bottles.
Species-specific analyses. A total of 217 different species or microbial “groupings”
(e.g., Bacteroides fragilis group or coagulase-negative Staphylococcus species) were
reported from positive bottles. Of these, 52 different species or microbial groupings
were found in $20 bottles (see Table S1 in the supplemental material): these included
31 Gram-positive species or groupings, 17 Gram-negative bacteria, and 4 species of
yeast. Forty-six bottles (0.3% of positive bottles) flagged positive, but no organism was
ever recovered or detected by acridine orange staining.
Histograms of select medically relevant Gram-positive microbes [Staphylococcus
aureus (n=3,893), Staphylococcus epidermidis (n=1,248), Streptococcus pneumoniae
(n=192), and Enterococcus faecium/Enterococcus faecalis (n=859)] are shown in Fig. 4.
All four species reached 95% and 99% times to positivity more quickly than the overall
TABLE 1 Comparison of blood culture times to positivity by indicated grouping
Grouping No. of bottlesa
Time to positivity (h)b
Mean T50 T90 T95 T99
All 13,592 21.1 16.5 38.5 56.5 103.5
Aerobic bottles 6,940 20.0 15.5 36.5 54.0 91.5
Anaerobic bottles 6,652 22.3 17.5 39.5 59.5 108.0
Bottles from children 823 20.0 16.5 36.0 44.0 84.0
S. aureus 3,893 18.4 16.0 29.5 39.0 72.0
Coagulase-negative Staphylococcus spp.c 2,208 23.5 20.5 35.5 46.0 86.5
E. coli 1,382 12.3 10.0 17.5 27.5 66.0
S. epidermidis 1,248 20.9 19.5 29.5 34.5 54.5
E. faecium/E. faecalis 859 15.7 13.0 25.5 34.5 64.5
Candida spp. 314 48.9 43.0 82.0 108.0 115.5
P. aeruginosa 298 22.2 16.0 45.0 57.5 96.0
S. pneumoniae 192 10.6 10.5 14.5 17.5 30.5
Cutibacterium spp. 121 103.9 106.0 115.5 118.0 118.0
B. fragilis 76 31.8 28.0 52.0 57.5 60.0
S. maltophilia 25 25.9 21.5 56.0 57.5 79.5
No growth 46 33.0 14.5 94.0 106.0 118.0
aThe total numbers of aerobic and anaerobic bottles were 7,113 and 6,804, respectively.
bTimes to achieve 50, 90, 95, and 99% of bottles positive are indicated as T50, T90, T95, and T99, respectively.
cThe “Coagulase-negative Staphylococcus spp.” grouping includes isolates not otherwise specified by row in the
table.
FIG 2 Time to positivity for blood culture bottles collected from children. Positive bottles (n= 823)
were plotted in 30-min intervals. After 4 days of incubation, 99.39% of bottles flagged positive.
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average (Table 1). S. pneumoniae had the shortest time to positivity of any microbe,
with 98.44% of bottles with this microorganism flagging positive within 24 h and 100%
within 48 h. The grouping coagulase-negative Staphylococcus was commonly found in
the data set and exhibited a histogram similar to those of other Gram-positive microbes.
Key Gram-negative bacteria recovered from positive bottles included Escherichia
coli (n=1,382), Pseudomonas aeruginosa (n=298), Stenotrophomonas maltophilia (n=25),
and Bacteroides fragilis group (n=76) (Fig. 5). E. coli reached 50% positivity faster than any
other microbe, at 10 h (Table 1). While 94.43% of bottles flagged positive in 24 h, a long
histogram tail was observed, with 25 bottles flagging positive over days 3 to 5. P. aerugi-
nosa had 97.99% of bottles flag positive after 3 days and only two bottles flag positive af-
ter 4 days. The data sets for S. maltophilia and B. fragilis were noteworthy because the
overwhelming majority of bottles (all but 1) flagged positive within 3 days.
To determine the growth patterns associated with fungemia, all Candida species
were evaluated (Fig. 6). Time to positivity was more evenly distributed across the 5-day
incubation time than the bacterial histograms. By the fourth day, 92.68% of bottles
flagged positive, leaving 23 remaining. The delayed time to positivity was also evident
in the times to achieve 50, 90, 95, and 99% positivity (Table 1).
Cutibacterium (formerly Propionibacterium) species are often considered contami-
nants, although this microbe has been implicated in causing serious disease (12–14).
The histogram of Cutibacterium species (Fig. 4) was strikingly different from those of
other microbial histograms. Only two bottles flagged positive after 3 days (1.65%). An
additional 30 bottles flagged positive by day 4 (26.45%), and 89 (73.55%) bottles
FIG 3 Evaluation of time to positivity for aerobic and anaerobic blood culture bottles. Positive
aerobic (n= 6,940) and anaerobic (n= 6,652) bottles were plotted in 30-min intervals. After 4 days of
incubation, 99.27% of aerobic bottles and 98.14% of anaerobic bottles flagged positive.
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flagged positive in the final 24 h. This delayed time to positivity was also notable in
Table 1.
Clinical impact of positive bottles after 4 days. Only 175 bottles (0.1% of all bot-
tles and 1.3% of positive bottles) flagged positive after 4 days of incubation. There
were 160 bottles that had no recorded impact in the patient’s medical record. Of these
bottles, 38 were specifically mentioned by medical staff as being “contaminated.”
Twenty-two bottles had a companion bottle in the culture flag positive with the same
organism before 96 h. Three of the 175 bottles resulted in orders for additional tests
FIG 4 Evaluation of time to positivity for select Gram-positive bacteria. Positive bottles were plotted in 30-min intervals. For each grouping, greater than
99.6% of bottles flagged positive after 4 days, except for bottles with Cutibacterium spp., only 26.45% of which were positive.
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that were never acted upon. Another bottle that grew Cutibacterium spp. delayed a
patient’s discharge by 2 days. A different bottle that grew Cutibacterium spp. resulted
in a visit to the Emergency Department, only to have repeat blood cultures show no
growth. Another bottle grew Lactobacillus spp. that resulted in an unremarkable clinic
visit. The remaining nine bottles caused a treatment adjustment. While it was difficult
to determine true significance, there was documented reservation of true pathogenic-
FIG 5 Evaluation of time to positivity for select Gram-negative bacteria. Positive bottles were plotted in 30-min intervals. For each grouping, greater than
99.3% of bottles flagged positive after 4 days.
FIG 6 Evaluation of time to positivity for Candida species. Positive bottles (n= 314) were plotted in
30-min intervals. After 4 days of incubation, 92.68% of bottles flagged positive.
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ity for at least three of the nine cultures, and three other cultures were from patients
who expired in less than 96 h. Even by the most conservative of estimates, the last day
of incubation was beneficial for,10 bottles (,0.006%).
Seeded experiment. Historically, microbes in the HACEK group have been consid-
ered slow growing, and an extended incubation might be necessary for recovery.
HACEK organisms were infrequently encountered in the retrospective review (e.g.,
Eikenella species, n=3), with the exception of Haemophilus species (n= 31). To enhance
the evaluable instances of the other HACEK organisms, a seeded study was performed
in triplicate using representative species: Aggregatibacter aphrophilus, Cardiobacterium
hominis, Eikenella corrodens, Kingella denitrificans, and Kingella kingae. The time to posi-
tivity of all isolates was less than 4 days for at least one bottle of the paired aerobic
and anaerobic set (Fig. 7). Bottles that did not flag positive are shown at the top of the
graph. Importantly, no bottles flagged positive between 4 and 5 days, suggesting no
added benefit of incubation time past 4 days for the HACEK group.
S. aureus bacteremia. Prolonged positivity and time to culture clearance are impor-
tant blood culture metrics when assessing a patient’s bacteremia. As shown in Fig. 4, S.
aureus was routinely recovered in #4 days, but nine bottles flagged positive after 4
days. None of these nine bottles resulted in therapeutic implications. For three bottles,
the companion bottle in the blood culture set had already flagged positive in #4 days.
Another three bottles had a different culture collected the same day that had already
flagged positive with S. aureus. Two bottles were from patients with intermittent S. aur-
eus-positive blood cultures that had flanking cultures collected before and after flag-
ging positive. Finally, one bottle was the last S. aureus-positive blood culture in a series
of cultures, with all subsequent blood cultures being negative.
Postimplementation. Based on the data reported in this study, our institution
implemented a 4-day incubation cutoff for blood cultures. Physicians still have the
option to call the laboratory and request extended incubation. As a result, the labora-
tory is on track to report .60,000 blood culture tests 1 day earlier in just the first year
of implementation. Another potential benefit has been a reduction in reporting of
blood culture contaminants. While still preliminary, with only 2 months of data, we
have seen a reduction in the recovery rate of Cutibacterium species relative to total
positives (0.07%; predicted reduction based on shortened incubation, 0.23%; previous
rate, 0.87%). Lastly, we were able to create additional instrument capacity without pur-
chasing additional units in our Virtuo system by removing all the negative bottles 1
day earlier. This proved especially valuable in the era of severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) and the corresponding massive increases in blood
culture requests.
FIG 7 Seeded blood cultures for HACEK isolates. Aerobic and anaerobic bottles are shown as filled
circles and open squares, respectively. The dashed line at 4 days denotes a theoretical 4-day cutoff.
Bottles that did not flag positive for growth are shown above. No bottles flagged positive after 4
days of incubation.
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Bloodstream infections are a significant cause of morbidity and mortality in the
United States, with an estimated burden of 72,000 to 85,000 deaths annually (15).
Continuously monitored blood culture systems are a mainstay in clinical microbiology
laboratories to test for these potentially life-threatening conditions. The goal of this
study was to assess the optimal incubation time for blood cultures using the BacT/
Alert Virtuo system paired with FA Plus (aerobic) and FN Plus (anaerobic) resin culture
bottles. A retrospective review of 158,710 blood culture bottles collected over 1 year
found only 175 (0.11%) flagged positive after 4 days of incubation. Chart review of
these 175 bottles revealed that less than 10 bottles had a positive impact on clinical
care, and some positives contributed to additional, unnecessary testing, delayed dis-
charges, and unnecessary health care visits. These findings suggested that a routine
incubation time of 4 days is sufficient for clinical laboratories using the Virtuo system.
Optimizing culture incubation time to minimize the recovery of clinically insignificant
cultures is appealing as blood culture contaminants can result in increased health care
costs, prolonged length of stay, and laboratory waste (16–18).
There is a precedent for reducing the standard incubation time of blood cultures on
automated systems. For years, the standard was 7 days. Publications from the 1990s
demonstrated that commonly used systems like the BacT/Alert could have a shortened
incubation period (19–22). The optimal incubation length varied by blood culture
system. Hardy et al. reported that$99% of cultures from pathogenic species were pos-
itive by 5 days and noted a 5-day incubation would significantly reduce recovered
Cutibacterium (Propionibacterium) species by 77% (19), strikingly similar to the work
presented here. The Difco ESP system was reported to have sufficient results, with a 4-
day incubation detecting 97.8% of all positives (3). The AccuMed ESP-384 system with
a 3-day incubation was considered sufficient, with 94.2% of positives detected (23).
There are reports of the Virtuo system having an even faster time to positivity com-
pared to other blood culture systems—BD Bactec FX (6, 24, 25) and the BacT/Alert 3D
system (8–10, 24, 26–28)—although the vast majority of these investigations used
seeded studies. It should be noted that the epidemiological prevalence of species
throughout these studies was similar to that in the present study. The most commonly
recovered microbes were coagulase-negative staphylococci, S. aureus, Enterococcus
species, E. coli, and S. pneumoniae. As for the theoretically missed species with a
reduced incubation, these were also similar: Cutibacterium (Propionibacterium) species,
Candida glabrata, and microbes of questionable clinical significance. Taken together,
the evidence within the present article supporting a 4-day incubation closely resem-
bles that of the past that led to the now 5-day standard incubation time.
To our knowledge, this is the largest study of its kind evaluating the outcomes of
blood cultures on the Virtuo system along with supplementary medical chart reviews.
Even a study of this size will not include the rarest of slow-growing pathogens. To miti-
gate this limitation, a seeded experiment of the HACEK group was included and
showed no difference between 4- and 5-day incubations. The HACEK group was histor-
ically often thought to require extended incubation for detection, but this has been
refuted previously (29, 30). An additional limitation of this study is the findings may
not be applicable to other blood culture systems or other laboratories with different
local microbiological populations. Furthermore, a criticism of this work might be that
the data come from a single microbiology laboratory, but cultures were received from
five hospitals, including an academic hospital, community hospitals, and a children’s
hospital. Lastly, there may be interest in establishing an even shorter incubation time
in the future. If a 3-day incubation was proposed using our data set, the five most
impacted species would be S. aureus, coagulase-negative Staphylococcus species,
Cutibacterium species, Candida species, and Sphingomonas species. Future studies are
needed to determine if shorter incubation periods are clinically feasible and could fur-
ther optimize patient care and laboratory testing.
If an institution was to reduce the blood culture incubation time, national guidelines
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from pertinent organizations must be considered. The Clinical and Laboratory Standards
Institute (CLSI) guidelines recommend a 5-day incubation time while also acknowledging
4 days, or even 3 days, might be adequate for some systems (31). The CLSI M47 docu-
ment (published in 2007) states adequate data from a shorter incubation time may per-
mit laboratories to adapt shorter protocols; this may be revised in updates to the M47
document. Other guidelines like those from the Infectious Diseases Society of America
(IDSA) may be impacted by a shortened incubation period. For example, uncomplicated
bacteremia is defined as patients with positive blood cultures and follow-up blood cul-
tures performed on specimens obtained 2 to 4days after the initial set that do not grow
methicillin-resistant S. aureus (MRSA) (32). This 2- to 4-day time period may need to be
adjusted in the setting of contemporary blood culture systems and media.
In conclusion, we found a 4-day incubation cutoff to detect the vast majority of
microorganisms detected on the BacT/Alert Virtuo system. We project that a 4-day
incubation on the Virtuo blood culture system not only will improve microbiological
workflows but also will improve patient care.
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